Results 131 to 140 of about 28,044 (159)

Promoting equitable access to financial services to end financial discrimination against cancer survivors in Europe: scientific and ethical reasons. [PDF]

ESMO Open
André F, Soldato D, Vaz-Luis I, Cervantes A, Peters S, Harbeck N, de Azambuja E, Blay JY.   +7 more
europepmc   +1 more source

Individually optimized estimation of energy expenditure in rescue workers using a tri-axial accelerometer and heart rate monitor. [PDF]

Front Physiol
Ogata H, Negishi Y, Koizumi N, Nagayama H, Kaneko M, Kiyono K, Omi N.   +6 more
europepmc   +1 more source

Real-Time Indoor Environmental Quality (IEQ) Monitoring Using an IoT-Based Wireless Sensing Network. [PDF]

Sensors (Basel)
Tsang TW, Mui KW, Wong LT, Chan AC, Chan RC.   +4 more
europepmc   +1 more source

What to Consider When Developing Multidomain Mobile Health Interventions for Lifestyle Management. [PDF]

JMIR Mhealth Uhealth
Weber M, Mattli R, Raab AM, Frei A, Haas K, Marcin T, Vorster A, Schmitt KU.   +7 more
europepmc   +1 more source

The Fundamental Fallacy of "Empathic AI". [PDF]

Hastings Cent Rep
Kreitmair K.
europepmc   +1 more source

Comparing Eye-Tracking and Verbal Reports in L2 Reading Process Research: Three Qualitative Studies. [PDF]

J Eye Mov Res
Yang C, Hu G, Que K, Fan N.
europepmc   +1 more source

A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC. [PDF]

Cancers (Basel)
Burcher K, Karukonda P, Kelsey C, Mullikin T, Antonia SJ, Oduah EI.   +5 more
europepmc   +1 more source

Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies. [PDF]

Cancers (Basel)
Roussot N, Kaderbhai C, Ghiringhelli F.
europepmc   +1 more source

Lung cancer immunotherapy in 2025: where we stand and what comes next? [PDF]

Front Immunol
Han J, Yang Z, Zhao H.
europepmc   +1 more source